Skip to main content

Animations

MJFF Publications

7281 - 7290 of 8808 Results
Title
Year
  • Year
  • 2016
  • 2018
  • 2025
  • 2021
  • 2022
  • 2020
  • 2024
  • 2024
  • 2022
  • 2017
  • Summary Details
    OPEN
    Title: Synthesis and characterization of a series of chiral alkoxymethyl morpholine analogs as dopamine receptor 4 (D4R) antagonists
    Journal Name: Bioorganic & Medicinal Chemistry Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bmcl.2016.03.102
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Mapping movement, mood, motivation and mentation in the subthalamic nucleus
    Journal Name: Royal Society Open Science
    Publisher: The Royal Society
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1098/rsos.171177
    Citation Count: 34
  • Summary Details
    RESTRICTED
    Title: Cropland associated with risk of Parkinson's disease in the northern Great Plains
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107288
    Citation Count: 0
  • Summary Details
    OPEN
    Title: The Experience of OFF Periods in Parkinson’s Disease: Descriptions, Triggers, and Alleviating Factors
    Journal Name: Journal of Patient-Centered Research and Reviews
    Publisher: Aurora Health Care, Inc.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.17294/2330-0698.1836
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00388-7
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
    Journal Name: Journal of Visualized Experiments
    Publisher: MyJove Corporation
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3791/58956-v
    Citation Count: 6
  • Summary Details
    RESTRICTED
    Title: Conquering Neurologic Diseases in Primary Care
    Journal Name: Primary Care: Clinics in Office Practice
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.pop.2024.03.001
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Disruption of the LRRK2‐FADD Interface Using Constrained Peptides
    Journal Name: Peptide Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/pep2.24374
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00404-w
    Citation Count: 15
  • Summary Details
    RESTRICTED
    Title: Tau/α‐synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27001
    Citation Count: 41
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.